In 2009, researchers reported that the density of CD56bright NK cells in the peripheral blood of active SLE patients was increased regardless of disease activity because of increased expression of type one interferon (NKp46/CD335) on CD56bright NK cells more than that of CD56dim subset (61). This evidence concerns the gene NCR1 and systemic lupus erythematosus.